At a Glance
Dosage
oral
| Level | DOI | 1cP-LSD |
|---|---|---|
| Threshold | 0.5 mg | 15 µg |
| Light | 0.5–1 mg | 25–75 µg |
| Common | 1–2 mg | 75–150 µg |
| Strong | 2–3 mg | 150–300 µg |
| Heavy | 3 mg | 300 µg |
Duration
oral
DOI
oral
Onset
Come Up
Onset: 1 hrs – 2 hrsCome Up: 1.5 hrs – 3 hrs
Total: 16 hrs – 24 hrs
1cP-LSD
oral
Peak
Offset
Afterglow
Onset: 20 min – 1 hrsCome Up: 45 min – 2 hrs 3 hrs – 5 hrs
Effects
Safety
Interaction: DOI + 1cP-LSD
No direct interaction data available between these substances. This does not mean the combination is safe.
DOI — Dangerous Interactions
No dangerous interactions recorded.
1cP-LSD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between DOI and 1cP-LSD?
DOI is classified as a Psychedelic (Substituted amphetamines) while 1cP-LSD is classified as a Psychedelic (Lysergamides). They share 46 effects in common, with 7 effects unique to DOI and 10 unique to 1cP-LSD.
Is it safe to combine DOI and 1cP-LSD?
There is no direct interaction data available for combining DOI and 1cP-LSD. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, DOI or 1cP-LSD?
At common doses via oral, DOI is typically dosed at 1–2 mg while 1cP-LSD is dosed at 75–150 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.